ד"ר אליזבת יובן וצלר היא פסיכיאטרית בכירה, מנהלת מחלקת פסיכיאטרית נשים במרכז הירושלמי לבריאות הנפש (איתנים). ד"ר יובן וצלר כיהנה בתור סגנית מנהלת מחלקה פסיכיאטרית א' בבית החולים תל השומר. כיום היא מלמדת הוראה קלינית בפקולטה לרפואה של האוניברסיטה העברית. כמו כן, היא חברה באגודה הישראלית לפסיכיאטריה ובאגודה הישראלית לפסיכיאטריה ביולוגית. ד"ר יובן וצלר בוגרת בית הספר לרפואה של הטכניון והתמחתה בפסיכיאטריה בבית החולים תל השומר. בנוסף, היא בוגרת תואר MSc באוניברסיטת מסטריכט בהולנד. ד"ר יובן וצלר לקחה חלק במחקרים רבים ופרסמה עשרות מאמרים מדעיים בתחומים מגוונים: תפקודים מיניים, הפרעה אובססיבית קומפולסיבית, דיכאון, פוסט טראומה, סכיזופרניה, אובדנות ועוד.
פרסומים אקדמיים
1. Gruenwald I, Vardi Y, Gartman I, Juven E, Sprecher E, Yarnitsky D, Miller A. Sexual dysfunction in females with multiple sclerosis: quantitative sensory testing. Mult Scler.
2007 Jan;13(1):95-105. 4.840; 27/194; 46/259; 34.
2. Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Papageorgiou K,Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder–a European multicenter study. Eur Neuropsychopharmacol.
Eur Neuropsychopharmacol. 2012 Apr;22(4):259-66. 4.239; 34/194; 62/259; 40/257; 23
3. Juven-Wetzler A, Bar-Ziv D, Cwikel-Hamzany S, Abudy A, Peri N, Zohar J. A pilot study of the "Continuation of Care" model in "revolving-door" patients.
Eur Psychiatry. 2012 May;27(4):229-33. 3.123; 52/142 (SCIE); 35/139 (SSCI); 6
4. Calati R, Crisafulli C, Balestri M, Serretti A, Spina E, Calabrò M, Sidoti A, Albani D, Massat I, Höfer P, Amital D, Juven-Wetzler A, Kasper S, Zohar J, Souery D, Montgomery S, Mendlewicz J. , Evaluation of the role of MAPK1 and CREB1 polymorphisms on treatment resistance, response and remission in mood disorder patients.
Prog Neuro-Psychopharmacol Biol Psychiatry. 2013 Jul 1;44:271-8. 4.187; 36/194; 63/259; 41/257; 15
5. Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Linotte S, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. The impact of Cytochrome P450 CYP1A2, CYP2C9, CYP2C19 and CYP2D6 genes on suicide attempt and suicide risk-a European multicentre study on treatment-resistant major depressive disorder. Eur Arch Psychiat Clin Neurosci. 2013 Aug;263(5):385-91. 3.569; 49/194; 39/142; 6
6. Amital D, Fostick L, Silberman A, Calati R, Spindelegger C, Serretti A, Juven-Wetzler A, Souery D, Mendlewicz J, Montgomery S, Kasper S, Zohar J. Physical co-morbidity among treatment resistant vs. treatment responsive patients with major depressive disorder.
Eur Neuropsychopharmacol. 2013 Aug;23(8):895-901. 4.239; 34/194; 62/259; 40/257; 5
7. Juven-Wetzler A, Cohen H, Kaplan Z, Kohen A, Porat O, Zohar J. Immediate ketamine treatment does not prevent posttraumatic stress responses in an animal model for PTSD.
Eur Neuropsychopharmacol. 2014 Mar;24(3):469-79. 4.239; 34/194; 62/259; 40/257; 12
8. Abudy A, Juven-Wetzler A, Zohar J. The different faces of Creutzfeldt-Jacob disease CJD in psychiatry.
Gen Hosp Psychiatry. 2014 May-Jun;36(3):245-8. 2.279; 73/142 (SCIE); 54/139 (SSCI); 2
9. Fabbri C, Marsano A, Albani D, Chierchia A, Calati R, Drago A, Crisafulli C, Calabrò M, Kasper S, Lanzenberger R, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A. PPP3CC gene: a putative modulator of antidepressant response through the B-cell receptor signaling pathway.
Pharmacogenomics J. 2014 Oct;14(5):463-72. 3.815; 46/167; 51/257; 15
10. Lochner C, Fineberg NA, Zohar J, van Ameringen M, Juven-Wetzler A, Altamura AC, Cuzen NL, Hollander E, Denys D, Nicolini H, Dell'Osso B, Pallanti S, Stein DJ. Comorbidity in obsessive-compulsive disorder (OCD): a report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS).
Compr Psychiatry. 2014 Oct;55(7):1513-9. 2.194; 77/142 (SCIE); 60/139 (SSCI); 15
11. Juven-Wetzler A, Fostick L, Cwikel-Hamzany S, Balaban E, Zohar J. Treatment with Ziprasidone for schizophrenia patients with OCD.
Eur Neuropsychopharmacol. 2014 Sep;24(9):1454-62. 4.239; 34/194; 62/259; 40/257; 4
12. Souery D, Calati R, Papageorgiou K, Juven-Wetzler A, Gailledreau J, Modavi D, Sentissi O, Pitchot W, Papadimitriou GN, Dikeos D, Montgomery S, Kasper S, Zohar J, Serretti A, Mendlewicz J. What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram.
World J Biol Psychiatry. 2015Oct; 16(7):472-82. 3.658; 37/142; 3
13. Fabbri C, Crisafulli C, Gurwitz D, Stingl J, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Girolamo GD, Serretti A. Neuronal cell adhesion genes and antidepressant response in three independent samples.
Pharmacogenomics J. 2015 Dec; 15(6):538-48. 3.815; 46/167; 51/257; 9
14. Höfer P, Schosser A, Calati R, Serretti A, Massat I, Kocabas NA, Konstantinidis A, Mendlewicz J, Souery D, Zohar J, Juven-Wetzler A, Montgomery S, Kasper S. The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment–a European multicentre study.
Int Clin Psychopharmacol. 2016 Jan;31(1):1-7. 2.968; 90/257; 55/142; 5
15. Fabbri C, Crisafulli C, Calati R, Albani D, Forloni G, Calabrò M, Martines R, Kasper S, Zohar J, Juven-Wetzler A, Souery D, Montgomery S, Mendlewicz J, Serretti A. Neuroplasticity and second messenger pathways in antidepressant efficacy: pharmacogenetic results from a prospective trial investigating treatment resistance.
Eur Arch Psychiat Clin Neurosci. 2017 Dec;267(8):723-735. 3.569; 49/194; 39/142; 1
16. Zohar J, Fostick L, Juven-Wetzler A, Kaplan Z, Shalev H, Schreiber G, Miroshnik N, Shalev AY, Stein DJ, Seedat S, Suliman S, Klein E. Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind Trial. J Clin Psychiatry. 2017 Jul 11. 5.291; 16/142 (SCIE); 5/121 (SSCI); 12/139 (SSCI); 0 Secondary Prevention of Chronic PTSD by Early and Short-Term Administration of Escitalopram: A Prospective Randomized, Placebo-Controlled, Double-Blind Trial.
17. Wetzler AJ, Elias R, Fostick L, Zohar J. Suicidal ideation versus suicidal obsession: a case report. CNS Spectr. 2007 Jul;12(7):553-6. 3.589; 46/194; 38/142; 6
18. Zohar J, Juven-Wetzler A, Myers V, Fostick L. Post-traumatic stress disorder: facts and fiction. Curr Opin Psychiatry. 2008 Jan;21(1):74-7. 4.020; 33/142 (SCIE); 20/139 (SSCI); 20
19. Zohar J, Sonnino R, Juven-Wetzler A, Cohen H. Can posttraumatic stress disorder be prevented?
CNS Spectr. 2009 Jan;14(1 Suppl 1):44-51. 3.589; 46/194; 38/142; 29
20. Zohar J, Juven-Wetzler A, Sonnino R, Cwikel-Hamzany S, Balaban E, Cohen H. New insights into secondary prevention in post-traumatic stress disorder.
Dialogues Clin Neurosci. 2011;13(3):301-9. 3.976; 67/259; 41
21. Abudy A, Juven-Wetzler A, Zohar J. Pharmacological management of treatment-resistant obsessive-compulsive disorder.
CNS Drugs. 2011 Jul;25(7):585-96. 4.394; 33/194; 34/257; 25/142; 28
22. Zohar J, Fostick L, Juven-Wetzler A. Obsessive-compulsive disorder Zohar J, Fostick L, Juven-Wetzler A. Obsessive-compulsive disorder New Oxford textbook .
Oxford University Press:Oxford UK. 2nd Edition , March 2009
23. Juven-Wetzler A, Sonnino R, Bar-Ziv D, Zohar J. Symptom exaggeration in posttraumatic stress disorder.
In: Nutt DJ, Stein M, Zohar J (Editors).
Post-traumatic stress disorder: diagnosis, management and treatment. Informa Healthcare, 2nd Edition, September 2009
24. Abudy A, Juven-Wetzler A, Sonnino R, Zohar J. Serotonin and beyond: a neurotransmitter perspective of OCD. Obsessive compulsive disorder current science and clinical practice. Wiley-Blackwell, 2012
פרסומים נוספים
זהר י, בר-זיו ד, יובן וצלר א. האם אפשר לחיות עם הפרעה טורדנית כפייתית?
מדיקל . 2010ינואר-פברואר: 28, 46-48.
[content_block id=2446 slug=rm-about-us]
